drug · small molecule
patient view →tavapadon
pre_registrationupdated 2mo agoby $ABBV AbbVie Inc.🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
indications
indications
Parkinson's Disease
targets
D(1A) dopamine receptorD(1B) dopamine receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that